Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding trastuzumab to chemotherapy improves outcomes in stage II or III breast cancer; results posted 2023-03-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Herceptin (trastuzumab) (trastuzumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-14